Mulmit

Pyxis Oncology, Inc.Pyxis Oncology, Inc.

PYXS Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3113,858,000-84,420,000-79,621,000-1.28
2024-12-3116,146,000-89,460,000-77,331,000-1.32

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-04Civik ThomasCEO & Chairman of the Board2,503,050
2026-08-20Dupont Jakob46,000
2026-08-12Civik ThomasInterim CEO250,956
2026-06-30Dupont Jakob35,000
2026-06-30Dupont Jakob35,000
2026-06-30Dupont Jakob35,000
2026-03-24Dupont Jakob45,867
2026-03-24Wadhane JitendraPrin Fin & Acct Officer109,461
2026-03-24Wadhane JitendraPrin Fin & Acct Officer262,635
2026-03-24FLAVIN JOHN L45,867
2026-03-24Metzger Michael A45,867
2026-03-24Lewis-Hall Freda C45,867

8-K events

FiledItems
2026-09-09Regulation FD disclosure · Other events · Financial statements and exhibits
2026-09-08Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-08-13Results of operations
2026-07-02Entry into a material agreement · Unregistered sales of equity securities · Regulation FD disclosure
2026-06-15Submission of matters to a vote
2026-05-14Results of operations
2026-04-30Officer or director change
2026-03-23Results of operations · Regulation FD disclosure
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.

한국 시장 대시보드Korea dashboard 미국·글로벌 대시보드US & Global dashboard